Related Experiment Video
Updated: Jun 25, 2026

13:08
Measurement of Factor V Activity in Human Plasma Using a Microplate Coagulation Assay
Published on: September 9, 2012
Immunochemical characterization of factor VIII inhibitors
Summary
Factor VIII inhibitors are IgG antibodies that inactivate factor VIII. Their unusual immunochemical properties, including IgG4 restriction, explain their lack of complement fixation and detection by standard assays.
Area of Science:
- Immunology
- Hematology
Background:
- Factor VIII inhibitors are antibodies that inactivate factor VIII procoagulant activity.
- These inhibitors, predominantly IgG, do not fix complement and are undetectable by standard immunoprecipitin assays.
Purpose of the Study:
- To investigate the unusual immunochemical properties of factor VIII inhibitors.
- To characterize the antigenic determinants and idiotypes of human anti-factor VIII antibodies.
Main Methods:
- Analysis of antibody class and subclass (IgG4).
- Assessment of light chain restriction (kappa).
- Identification of antigenic determinants and idiotypes using rabbit anti-idiotype serum and monoclonal antibodies.
Main Results:
- Factor VIII inhibitors exhibit consistent kappa light chain restriction.
- Most allo- and auto-antibodies against factor VIII (anti-VIII:C) are predominantly or exclusively IgG4.
- This IgG4 predominance may explain the lack of complement fixation and immunoprecipitation.
- Human anti-VIII:C antibodies react with multiple antigenic determinants.
- Distinct anti-VIII:C idiotypes have been identified.
Conclusions:
- The immunochemical properties of factor VIII inhibitors, particularly IgG4 restriction, are key to their function and detection challenges.
- Characterization of epitopes and idiotypes offers new avenues for immunochemical analysis of these inhibitors.
Related Concept Videos
Anticoagulant Drugs: Low-Molecular-Weight Heparins
Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
Anticoagulant Drugs: Vitamin K Antagonists and Direct Oral Anticoagulants
Oral anticoagulants are vital tools in preventing and treating blood clotting disorders. This diverse class of medications can be categorized as vitamin K antagonists, exemplified by warfarin, and direct thrombin inhibitors (DTIs), such as dabigatran, as well as factor Xa inhibitors, including rivaroxaban.
Warfarin, a prominent vitamin K antagonist family member, exerts its effect by inhibiting the enzyme VKORC1 (vitamin K epoxide reductase complex 1). By hindering this enzyme, warfarin...
Warfarin, a prominent vitamin K antagonist family member, exerts its effect by inhibiting the enzyme VKORC1 (vitamin K epoxide reductase complex 1). By hindering this enzyme, warfarin...

